Equities

EMV Capital PLC

EMVC:LSE

EMV Capital PLC

Health CareMedical Equipment and Services
  • Price (GBX)53.50
  • Today's Change0.00 / 0.00%
  • Shares traded47.79k
  • 1 Year change-13.01%
  • Beta2.3530
Data delayed at least 15 minutes, as of Oct 07 2024 16:28 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year EMV Capital PLC grew revenues 43.92% from 1.00m to 1.45m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -3.09m to -2.64m.
Gross margin79.33%
Net profit margin-170.92%
Operating margin-148.76%
Return on assets-13.31%
Return on equity-15.86%
Return on investment-15.69%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at EMV Capital PLC fell by 652.00k. Cash Flow from Financing totalled 1.39m or 96.12% of revenues. In addition the company used 3.14m for operations while cash from investing totalled 1.11m.
Cash flow per share-0.1113
Price/Cash flow per share--
Book value per share0.7904
Tangible book value per share0.6753
More ▼

Balance sheet in GBPView more

EMV Capital PLC has a Debt to Total Capital ratio of 6.58%, a higher figure than the previous year's 6.48%.
Current ratio0.3153
Quick ratio0.3086
Total debt/total equity0.0688
Total debt/total capital0.0658
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.